Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial

Hoster, Eva; Delfau-Larue, Marie-Helene; Macintyre, Elizabeth; Jiang, Linmiao; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles; Thieblemont, Catherine; Tilly, Herve; Wirths, Stefan; Feugier, Pierre; Huebel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C.; Dreyling, Martin; Pott, Christiane

Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial

Autor(en):

Hoster, Eva; Delfau-Larue, Marie-Helene; Macintyre, Elizabeth; Jiang, Linmiao; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles; Thieblemont, Catherine; Tilly, Herve; Wirths, Stefan; Feugier, Pierre; Huebel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C.; Dreyling, Martin; Pott, Christiane

Tübinger Autor(en):

Wirths, Stefan

Erschienen in:

Journal of Clinical Oncology (2024), Bd. 42, H. 5, S. 538-549

Verlagsangabe:

Philadelphia : Lippincott Williams & Wilkins

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1200/JCO.23.00899

ISSN:

0732-183X